key articles
Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma
Tuesday, 5 October 2010- Bacillus Calmette-Guerin (BCG)-refractory generated a high risk to patients with bladder cancer during treatment. Tyrosine kinase receptor (TKR) and TKR-mediated signal transduction pathways play an...
Edited by: JV
Age affects bladder cancer treatment outcomes
Tuesday, 28 September 2010- Octogenarians with non-muscle-invasive bladder cancer (NMIBC) have the worst outcomes after bladder-preserving treatment, data show.
Researchers at Wakayama Medical University in Wakayama, Japan,...
Edited by: ES
Prognostic value of radical cystoprostatectomy in men with bladder cancer infiltrating prostate
Friday, 24 September 2010- A group of researchers conducted a study to evaluate the advancement of incidentally diagnosed prostate cancer in specimen after cystoprostatectomies caused by muscle-invasive bladder cancer.
P....
Edited by: JV
Analysis of early complications of robotic-assisted radical cystectomy
Wednesday, 15 September 2010- A group of researchers in the UK conducted a study to analyse the early complications of robotic-assisted laparoscopic radical cystectomy (RARC) with extracorporeal ileal conduit or orthotopic...
Edited by: JV
Detecting circulating tumour cells in patients with NMABC
Thursday, 2 September 2010- A group of researchers conducted a study to prospectively detect and evaluate the biological significance of circulating tumour cells (CTC) in patients with bladder cancer, especially in those patients...
Edited by: JV
Observational study: Does adjuvant chemotherapy following radical cystectomy benefit the highest risk patients?
Wednesday, 18 August 2010- According to the findings of a retrospective analysis published recently in Clinical Cancer Research, the use of adjuvant chemotherapy (AC) after radical cystectomy is of benefit to patients with...
Edited by: ES
Extended lymphadenectomy in bladder cancer
Monday, 9 August 2010- Radical cystectomy with pelvic lymph node dissection (PLND) is the preferred treatment for invasive bladder cancer. It not only results in the best disease-free term survival rates, but also provides the...
Edited by: JV
FGFR3 mutation analysis on voided urine: non-invasive tool to detect BCa recurrence
Tuesday, 29 June 2010- New peptide receptors study findings have been reported by researchers at Erasmus Medical Center, Department of Pathology in Rotterdam, the Netherlands.
"Mutations in the fibroblast growth factor...
Edited by: JV
Clinical outcomes of primary bladder carcinoma in situ after BCG therapy
Tuesday, 22 June 2010- The natural history of primary bladder carcinoma in situ has not been well described. D.C. Chade and colleagues conducted a study to describe patterns of disease recurrence and progression, and identify...
Edited by: JV
